Severity of cerebral white matter lesions and infarcts in patients with transient or moderately disabling cerebral ischaemia: Reproducibility of grading by neurologists

European Journal of Neurology

Volumn 13, Issue 8, 2006, Pages 901-903

  De Schryver, E L L M ^a   Van Gijn, J ^a   Kappelle, L J ^a   Koudstaal, P J ^b   Algra, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cerebral infarct; Grading; Infarct; Leukoaraiosis; White matter lesions

Indexed keywords

ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; WHITE MATTER;

BRAIN INFARCTION; BRAIN INJURIES; BRAIN ISCHEMIA; CONFIDENCE INTERVALS; DISABILITY EVALUATION; DISABLED PERSONS; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33746389667     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01269.x     Document Type: Article

References (13)

1. Longstreth WT Jr, Arnold AM, Manolio TA, et al. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3301 elderly people. The cardiovascular health study. Collaborative Research Group. Neuroepidemiology 2000; 19: 30-42.
2. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 2002; 44: 1246-1252.
3. Hijdra A, Verbeeten B Jr, Verhulst JA. Relation of leukoaraiosis to lesion type in stroke patients. Stroke 1990; 21: 890-894.
4. Bots ML, van Swieten JC, Breteler MM, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam study. Lancet 1993; 341: 1232-1237
5. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam scan study. Annals of Neurology 2000; 47: 145-151.
6. van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J. Hypodensity of the cerebral white matter in patients with transient ischaemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Annals of Neurology 1992; 32: 177-183.
7. Gorter JW, on behalf of the SPIRIT and EAFT Study Groups. Major bleeding during anticoagulation after cerebral ischaemia: patterns and risk factors. Neurology 1999; 53: 1319-1327.
8. Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM. Leukoaraiosis is associated with warfarin-related hemorrhage following ischaemic stroke. Neurology 2002; 59: 193-197.
9. Pantoni L, Inzitari D. New clinical relevance of leukoaraiosis. European Task Force on Age-related White Matter-changes [letter]. Stroke 1998; 29: 543.
10. De Schryver ELLM, on behalf of the European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Group. Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. Cerebrovascular Diseases 2000; 10: 147-150.
11. De Schryver ELLM, on behalf of the European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Group. ESPRIT: protocol change. Cerebrovascular Diseases 2001; 11: 286.
12. van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J. Grading white matter lesions on CT and MRI: a simple scale. Journal of Neurology, Neurosurgery and Psychiatry 1990; 53: 1080-1083.
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.